Evidence map›Paper›PMID 24009526›Full record

ArticlePLoS genetics2013

Comparative oncogenomic analysis of copy number alterations in human and zebrafish tumors enables cancer driver discovery.

GuangJun Zhang, Sebastian Hoersch, Adam Amsterdam, Charles A Whittaker, Eline Beert, Julian M Catchen, Sarah Farrington, John H Postlethwait, Eric Legius, Nancy Hopkins and 1 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. CXXC5: A novel regulator and coordinator of TGF-β, BMP and Wnt signaling.Journal of cellular and molecular medicine · 2019
    Review
  8. Identification ofOncotarget · 2018
    Article
  9. Article
  10. Atrazine exposure elicits copy number alterations in the zebrafish genome.Comparative biochemistry and physiology. Toxicology & pharmacology : CBP · 2017
    Article
  11. Article
  12. Article
  13. Selenoprotein H is an essential regulator of redox homeostasis that cooperates with p53 in development and tumorigenesis.Proceedings of the National Academy of Sciences of the United States of America · 2016
    Article
  14. Genomic Approaches to Zebrafish Cancer.Advances in experimental medicine and biology · 2016
    Review
  15. Review
  16. Cross-species oncogenomics using zebrafish models of cancer.Current opinion in genetics & development · 2015
    Review
  17. Review
  18. Zebrafish models of cancer: progress and future challenges.Current opinion in genetics & development · 2014
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 3 countries.

GuangJun ZhangDavid H. Koch Institute for Integrative Cancer Research, MIT, Cambridge, Massachusetts, United States of America.
Sebastian Hoersch
Adam Amsterdam
Charles A Whittaker
Eline Beert
Julian M Catchen
Sarah Farrington
John H Postlethwait
Eric Legius
Nancy Hopkins
Jacqueline A Lees
Koch Institute for Integrative Cancer Research At MITAllen Institute · USKU Leuven · BEUniversity of Oregon · US

Funding

VIRUS PRODUCTION COREP30CA014051 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI MATTHEW G. VANDER HEIDEN · 1985 to 2026
$93.9M
RESOURCES FOR TELEOST GENE DUPLICATES AND HUMAN DISEASER01RR020833 · NCRR · UNIVERSITY OF OREGON · PI POSTLETHWAIT, JOHN H. · 2005 to 2011
$3.6M
Using Zebrafish to Identify and Analyze Cancer GenesR01CA106416 · NCI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI LEES, JACQUELINE A. · 2006 to 2010
$1.9M
Elucidating the effects of structural variation on cis-regulation in sticklebackF32GM095213 · NIGMS · UNIVERSITY OF OREGON · PI CATCHEN, JULIAN MICHAEL · 2010 to 2012
$153k
NCI NIH HHS CA106416NCI NIH HHS P30 CA014051NCI NIH HHS R01 CA106416NCRR NIH HHS R01 RR020833NCRR NIH HHS R0I RR020833NIGMS NIH HHS 1F32GM095213-01NIGMS NIH HHS F32 GM095213
6 · The paper itself

Abstract

The identification of cancer drivers is a major goal of current cancer research. Finding driver genes within large chromosomal events is especially challenging because such alterations encompass many genes. Previously, we demonstrated that zebrafish malignant peripheral nerve sheath tumors (MPNSTs) are highly aneuploid, much like human tumors. In this study, we examined 147 zebrafish MPNSTs by massively parallel sequencing and identified both large and focal copy number alterations (CNAs). Given the low degree of conserved synteny between fish and mammals, we reasoned that comparative analyses of CNAs from fish versus human MPNSTs would enable elimination of a large proportion of passenger mutations, especially on large CNAs. We established a list of orthologous genes between human and zebrafish, which includes approximately two-thirds of human protein-coding genes. For the subset of these genes found in human MPNST CNAs, only one quarter of their orthologues were co-gained or co-lost in zebrafish, dramatically narrowing the list of candidate cancer drivers for both focal and large CNAs. We conclude that zebrafish-human comparative analysis represents a powerful, and broadly applicable, tool to enrich for evolutionarily conserved cancer drivers.

Indexed as

Chromosome AberrationsGenes, NeoplasmAneuploidyAnimalsDNA Copy Number VariationsGene Expression Regulation, NeoplasticGenome, HumanGenomicsHigh-Throughput Nucleotide SequencingHumansNeurilemmomaOligonucleotide Array Sequence AnalysisZebrafish

Identifiers

PMID24009526
PMCPMC3757083
OpenAlexW2053929101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.